Pulmonary Fellowship, University of Colorado, 1982-1984

Internal Medicine Residency, Emory University School of Medicine,  1976-1979

MD Cum Laude, Emory University School of Medicine, 1976

BA, Emory College, 1972

1975 – Alpha Omega Alpha

1988 – Emory House Staff Teaching Award—VA Medical Center, Atlanta, GA

2013 – 2017 – Castle Connolly Regional Top Doctor (Pulmonology)

Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM.A clinical, radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 13:97-103.

Watters LC, Cytotoxic drugs for non-neoplastic disorders of the respiratory system. In: Cherniack RM, ed. Drugs for the respiratory system. Grune and Stratton, Inc. Orlando; 1986, pp. 139-164.

Watters LC, Schwarz MI, Waldron JA, Dunn TL, Cherniak RM, Stanford RE, King TK. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135:696-704.

Watters LC. Chronic noninfectious alveolar filling diseases. In: Schwarz MI, King TK, eds. Interstitial Lung Disease, first edition 1987, Brian-Decker, Ontario, Canada; pp. 239-291

Watters LC. Granulomatous vasculitides of the lung. In: Kelley W, ed. Textbook of Internal Medicine, 1989. J.B. Lippincott Co., Philadelphia, PA; pp. 1914-1919.

Watters LC. Miscellaneous interstitial lung diseases. In: Kelly W, ed. Textbook of Internal Medicine, first edition 1989. J.B. Lippincott Co., Philadelphia, PA; pp. 1926-1930.     Watters LC. Chronic alveolar filling disease. In: Schwarz MI, King TE, eds. Interstitial Lung Disease, second edition, 1993. Mosby Year Book, St. Louis; pp. 309-366.   Watters LC. Update in Diagnosis of Fibrotic Interstitial Lung Disease. Atlanta Medicine. Journal of the Medical Association of Atlanta 2017; 88:6-11.